Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000171655 | SCV000050681 | uncertain significance | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Ce |
RCV000171655 | SCV001148553 | uncertain significance | not provided | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000114990 | SCV001498699 | uncertain significance | Atrial fibrillation, familial, 7 | 2024-06-30 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 305 of the KCNA5 protein (p.Ala305Thr). This variant is present in population databases (rs199794307, gnomAD 0.006%). This missense change has been observed in individual(s) with atrial fibrillation (PMID: 23264583, 24144883). ClinVar contains an entry for this variant (Variation ID: 127136). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Experimental studies have shown that this missense change affects KCNA5 function (PMID: 23264583, 28803858). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV000114990 | SCV002782321 | uncertain significance | Atrial fibrillation, familial, 7 | 2022-03-01 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000114990 | SCV000148899 | pathogenic | Atrial fibrillation, familial, 7 | 2013-05-01 | no assertion criteria provided | literature only |